AbbVie
ABBV
#25
Rank
ยฃ386.57 B
Marketcap
ยฃ218.70
Share price
0.94%
Change (1 day)
24.72%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of June 2026 : ยฃ103.24 Billion

According to AbbVie's latest financial reports the company's total assets are ยฃ103.24 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-12-31ยฃ99.47 B-7.65%
2024-12-31ยฃ107.70 B1.86%
2023-12-31ยฃ105.73 B-7.84%
2022-12-31ยฃ114.73 B5.69%
2021-12-31ยฃ108.55 B-1.73%
2020-12-31ยฃ110.46 B62.54%
2019-12-31ยฃ67.95 B45.34%
2018-12-31ยฃ46.75 B-10.73%
2017-12-31ยฃ52.37 B-2.23%
2016-12-31ยฃ53.56 B49.64%
2015-12-31ยฃ35.79 B102.57%
2014-12-31ยฃ17.67 B-0.17%
2013-12-31ยฃ17.70 B5.93%
2012-12-31ยฃ16.70 B33.05%
2011-12-31ยฃ12.55 B-8.26%
2010-12-31ยฃ13.69 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
ยฃ153.69 B 48.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ113.14 B 9.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ73.08 B-29.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ24.51 B-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ37.71 B-63.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ67.83 B-34.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ88.51 B-14.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ72.67 B-29.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ4.09 B-96.03%๐Ÿ‡บ๐Ÿ‡ธ USA